Skip to main content

Table 4 Correlations between relative expression of circANKRD36 and the mRNA expression level of ANKRD36 with clinical and laboratory characteristics in patients with CKD

From: The expression profile of circANKRD36 and ANKRD36 as diagnostic biomarkers of chronic kidney disease in patients with type 2 diabetes mellitus

Variables

circANKRD36

ANKRD36

r

p

r

p

Duration of diabetes (years)

0.460

˂0.001*

0.511

<0.001*

Body mass index (kg/m2)

0.246

0.058

0.044

0.741

Waist/hip ratio

0.139

0.290

0.102

0.440

Systolic blood pressure

0.207

0.112

0.056

0.666

Diastolic blood pressure

0.282

˂0.001*

0.380

˂0.001*

Total cholesterol (mg/dl)

0.117

0.372

0.180

0.058

Triglycerides (mg/dl)

0.383

˂0.001*

0.346

˂0.001*

LDL cholesterol (mg/dl)

0.371

˂0.001*

0.453

<0.001*

HDL cholesterol (mg/dl)

−0.039

0.770

−0.081

0.537

FPG (mg/dl)

0.459

˂0.001*

0.522

˂0.001*

HbA1c (%)

0.345

˂0.001*

0.508

˂0.001*

eGFR (mL/min)

−0.484

˂0.001*

−0.654

˂0.001*

Serum creatinine (mg/dl)

0.567

˂0.001*

0.493

<0.001*

UACR (mg/g)

0.589

˂0.001*

0.840

<0.001*

  1. T2DM Type 2 diabetes mellitus, FPG Fasting plasma glucose, HbA1c Hemoglobin, A1c Estimated glomerular filtration rate, UACR Urinary albumin-creatinine ratio, circANKRD36 Circular ankyrin repeat domain 36
  2. *P < 0.05